CompletedNot Applicable

Retrospective Study on Myoelectric Elbow-Wrist-Hand Orthosis User Outcomes

United States21 participantsStarted 2022-10-05

Plain-language summary

The objective of this study is to retrospectively evaluate the outcomes and clinical benefits provided by this brace to adult patients with upper limb impairment or paralysis due to brachial plexus, stroke (CVA), spinal cord injury, or other neurological disease or injury.

Who can participate

Age range65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults, 65 years and older at the time of MyoPro delivery * Completed the DASH questionnaire at evaluation before receiving the MyoPro * Completed the DASH questionnaire at least six months after receiving the MyoPro * Has intact cognition * Able to clearly and verbally communicate in the English language Exclusion Criteria: * Life-changing event(s) or change(s) in medical status that affected ability to use the MyoPro * Did not complete the DASH after receiving the MyoPro * Other conditions (e.g., cognitive issues) or circumstances that would preclude safe and/or effective participation

What they're measuring

Disabilities of the Arm, Shoulder and Hand (DASH)

Timeframe: Pre-MyoPro

Disabilities of the Arm, Shoulder and Hand (DASH)

Timeframe: At least six months Post-MyoPro

Trial details

NCT IDNCT05575674

SponsorMyomo

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2023-04-11

View on ClinicalTrials.gov More Stroke trials